Singapore · Biotechnology
Singapore · BiotechnologyEsco Group
Esco Group operates as a life science company with a diversified portfolio and sales.
PrivateFor profit
Why reach out now
What the record says about Esco Group as a customer or partner.
- Bigger than its listed size1,195 people list it on LinkedIn, above its 501-1000 band: it has likely grown since.
- 36 apps, 8 downloadsA consumer audience on mobile as well as the web.
- Has bought 1 companyIt has done deals before: a sign it is open to partnerships.
Against its peers
Set against 55 Biotechnology companies in Singapore. The ring marks the typical peer.
Across all 5.9M companies: larger than 95% of those with a size listed; older than 88% of those with a founding year; website ranked #7,776,193 in the world, about 715 visits a month. 1,195 people list it on LinkedIn, and 71,850 follow it.
About Esco Group
Esco Lifesciences Group is a world-leading manufacturer of laboratory, pharmaceutical equipment, bioprocess tools and IVF medical devices, delivering sustainable workflow solutions to advance global health. Since 1978, the Singapore-based company is committed to excellence, ensuring forward-thinking technology, responsive support, and reliability, making Esco a trusted partner for the life science and medical markets in more than 150 countries. Our Vision Strategically positioned to bridge the East and West, Esco… Read all
Esco Lifesciences Group is a world-leading manufacturer of laboratory, pharmaceutical equipment, bioprocess tools and IVF medical devices, delivering sustainable workflow solutions to advance global health. Since 1978, the Singapore-based company is committed to excellence, ensuring forward-thinking technology, responsive support, and reliability, making Esco a trusted partner for the life science and medical markets in more than 150 countries. Our Vision Strategically positioned to bridge the East and West, Esco aspires to become the leading provider of life science and fertility tools, delivering sustainable technologies that foster a healthier, more equitable, and resilient future. Our Mission We provide cutting-edge, sustainable workflow solutions that empower scientists and innovators to advance global health and enhance quality of life. ROOTED IN VALUES; DRIVEN BY SUCCESS
BiotechnologyLife ScienceManufacturingBiosafety CabinetDucted & Ductless Fume HoodLaminar Clean BenchLab Freezer & RefrigeratorLab Animal WorkstationCO2 IncubatorLab Incubator & OvenPCR Thermal CyclerBenchtop IncubatorIVF WorkstationLaboratory CentrifugeLaboratory ShakerPCR CabinetTime-Lapse Embryo Incubator
Funding, as listed
What the source datasets report. We have not watched these rounds ourselves.
$200M
raised in total across 1 round
Last raised May 2021, 5 years ago
- Rounds
- 1
- Latest round
- Series A
- Latest amount
- $200M
Corporate family
Where it sits in its group, and the deals it has done.
Key facts
Who started it and how it trades.
- Founded by
- Eugène Schmidt
- Apps
- 368 downloads
Every detail we hold
Everything the source datasets list about Esco Group, field by field. Contact details are held but never shown.
The company8 fields
- Name
- Esco Group
- Type
- For profit
- Status
- Private
- Founded
- 1978
- Founders
- Eugène Schmidt
- Industry
- Biotechnology
- Categories
- Biotechnology, Life Science, Manufacturing
- Specialities
- Biosafety Cabinet, Ducted & Ductless Fume Hood, Laminar Clean Bench, Lab Freezer & Refrigerator, Lab Animal Workstation, CO2 Incubator, Lab Incubator & Oven, PCR Thermal Cycler, Benchtop Incubator, IVF Workstation, Laboratory Centrifuge, Laboratory Shaker, PCR Cabinet, Time-Lapse Embryo Incubator
Where3 fields
- City
- Singapore
- Country
- Singapore
- Markets
- Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia
Size and reach7 fields
- Staff band
- 501-1000
- People on LinkedIn
- 1,195
- LinkedIn followers
- 71,850
- Web traffic rank
- #7,776,193
- Monthly web visits
- 715
- Apps
- 36
- App downloads
- 8
Show 9 more fieldsShow fewer fields
Funding, as listed6 fields
- Total
- $200,000,000 USD
- Rounds
- 1
- Latest round
- Series A
- Latest round date
- May 2021
- Latest amount
- 200,000,000 USD
- Listing status
- private
Corporate family1 field
- Acquisitions made
- 1
About this record2 fields
- Sources
- Crunchbase, LinkedIn
- Last imported
- Sept 2026
Growth, as the source summarises it
Esco Group may be growing as evidenced by the reported solid Q1 fiscal 2024 results, which included increased sales and orders. The company is also mentioned as a key company in the in vitro fertilization (IVF) devices market, which is projected to grow by USD 411.62 million from 2023-2028, indicating a positive outlook for its products in the life sciences industry. Furthermore, Esco Group is listed among companies in the fertility treatments market, which is projected to show strong growth, suggesting an expanding market presence.
Investors, as the source summarises it
Esco Lifesciences's investment strategy appears to focus on companies that operate within the life sciences and healthcare sectors, with a particular interest in biotechnology, medical devices, and health care. Their investments span various geographic locations, including the United Kingdom and China, indicating a willingness to invest internationally. The diversity in cities and regions suggests that Esco Lifesciences does not limit its investments to a specific locale within a country. The firm participates in various funding rounds, from seed to series A and corporate rounds, showing flexibility in the maturity stage of the companies they invest in. However, Esco Lifesciences does not typically take a lead role in the investments, preferring to be one of several investors. Considering Esco Lifesciences's recent investments and the global trend towards innovative healthcare solutions, companies that are developing cutting-edge biotechnologies, advanced medical devices, or novel healthcare services, particularly those with a sustainable and scalable model, would likely be attractive to Esco Lifesciences for future investments.
Companies like Esco Group
Biotechnology in Singapore.
ASLAN PharmaceuticalsSingapore · 11-50 peoplefounded 32 years later
RVAC MedicinesSingapore · 51-100 peoplefounded 43 years later
CerecinAnson House · 11-50 peoplesmaller: 6k followers
Curiox BiosystemsSingapore · 11-50 peoplesmaller: 5k followers
Eywa Pharma101-250 peoplefounded 37 years later
Aevice HealthSingapore · 11-50 peoplefounded 38 years laterBuild a lead list
55 Biotechnology companies in Singapore, filtered by size, age and reach, ready to export with emails on Pro.